Gaining exposure to biotech in times of uncertainty

Omicron variant saw wild price jumps

clock • 4 min read
The Omicron variant may prove to be the catalyst for recovery in biotech.

The Omicron variant may prove to be the catalyst for recovery in biotech.

The end of November saw the largest one-day fall in stock prices globally since June 2020, as investors reacted to the potential economic impact of a possible fourth wave of Covid-19, manifest in the new and ominously named Omicron variant of the Sars-Cov-2 virus.

But the panic selling was not entirely across the board: on the same day, the US biotech firm Moderna, one of three main suppliers of a Covid vaccine, saw its share price jump by 25%, adding a tidy $35bn...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Technology

Industry Voice Video: Wellington Global Impact Bond Fund

Celebrating the fund’s three-year anniversary

Celebrating the fund's three-year anniversary

Campe Goodman, CFA, Fixed Income Portfolio Manager and Paul Skinner, Investment Director at Wellington Management
clock 26 May 2022 • 2 min read
Helen Pridham

Helen Pridham: Industry pays tribute to trailblazing journalist and businesswoman

Founder of The Pridham Report

James Baxter-Derrington
clock 19 May 2022 • 5 min read
The Investment Marketing and Innovation Awards are back as a face-to-face event

Investment Week reveals shortlist for Investment Marketing & Innovation Awards 2022

Book your place here

clock 19 May 2022 • 1 min read